Roche announces FDA approval for COVID-19 test

By staff writers

Roche announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for its Cobas SARS-CoV-2 nucleic acid test. The test is designed for use on the Cobas Liat system.

Through the authorization, symptomatic and asymptomatic individuals can be tested for COVID-19 at the point of care, with results made available within 20 minutes. The company said the polymerase chain reaction (PCR) test offers broad strain coverage of SARS-CoV-2 variants.

The test will be made available in July.

Copyright © 2021

To read this and get access to all of the exclusive content on, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?